LEO PHARMACEUTICAL PRODUCTS, LTD. V. KAPPOS , No. 12-1520 (Fed. Cir. 2012)

Annotate this Case

Download PDF

Case: 12-1520 Document: 31 Page: 1 Filed: 09/27/2012 NOTE: This order is nonprecedential. WIniteb ~tate5 (!Court of ~peaI5 for tbe jfeberaI (!Circuit LEO PHARMACEUTICAL PRODUCTS, LTD. Appellant, v. DAVID J. KAPPOS, DIRECTOR, UNITED STATES PATENT AND TRADEMARK OFFICE, Appellee, AND GALDERMA R&D, Appellee. 2012-1520 (Reexamination No. 95/000,153) Appeal from the United States Patent and Trademark Office, Board of Patent Appeals and Interferences. ON MOTION ORDER Case: 12-1520 Document: 31 Page: 2 Filed: 09/27/2012 2 LEO PHARMACEUTICAL PRODUCTS V. KAPpos The Director of the United States Patent and Trademark Office and Galderma R&D ("Galderma") each move for a 50-day extension of time, until November 16, 2012, to file their principal briefs. Leo Pharmaceutical Products, Ltd. opposes. Upon consideration thereof, IT Is ORDERED THAT: The motions are granted. Galderma's and the Director's principal briefs are due November 16, 2012. FOR THE COURT SEP 21 2012 Date cc: Andrew D. Meikle, Esq. Raymond T. Chen, Esq. Martin B. Pavane, Esq. s27 /s/ Jan Horbaly Jan Horbaly Clerk u.s.11fEFEDERAtCrRCUITfOR COuJ't~~ SEP 272012 JAN HORBALY ClERK

Some case metadata and case summaries were written with the help of AI, which can produce inaccuracies. You should read the full case before relying on it for legal research purposes.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.